Abgenomics

AbGenomics (AbGenomics International, Inc.) is a clinical-stage biopharmaceutical company founded in 2000 with offices in the San Francisco Bay Area, California and an R&D center in Taipei, Taiwan. It develops targeted antibody therapeutics for immune-mediated inflammatory disease and cancer, built on a PSGL-1 T-cell checkpoint regulator platform, with clinical candidates including neihulizumab (AbGn-168H / ALTB-168) and the antibody-drug conjugate AbGn-107. The company rebranded as AltruBio, Inc. in 2020 and now operates at altrubio.com; the original abgenomics.com domain is a parked for-sale listing. It is a therapeutics developer, not a software vendor: it publishes no developer program, no public API, no SDKs and no machine-readable API description of any kind.

Abgenomics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Therapeutics.

Abgenomics’ developer surface includes support and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub

7.1/100 minimal Agent 0/100 human only Full breakdown ↓
scored 2026-09-06 · rubric v0.19.0

0 APIs

Company Biotechnology Pharmaceuticals Life Sciences Therapeutics Clinical Research Immunology Oncology

Kin Score

Kin Score How this is scored →
scored 2026-09-06 · rubric v0.19.0

Composite quality — 7.1/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.8 / 17

Access Clarity 1.8 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.9 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Well-Known Document 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/abgenomics: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: abgenomics
name: Abgenomics
description: 'AbGenomics (AbGenomics International, Inc.) is a clinical-stage biopharmaceutical company founded in 2000 with
  offices in the San Francisco Bay Area, California and an R&D center in Taipei, Taiwan. It develops targeted antibody therapeutics
  for immune-mediated inflammatory disease and cancer, built on a PSGL-1 T-cell checkpoint regulator platform, with clinical
  candidates including neihulizumab (AbGn-168H / ALTB-168) and the antibody-drug conjugate AbGn-107. The company rebranded
  as AltruBio, Inc. in 2020 and now operates at altrubio.com; the original abgenomics.com domain is a parked for-sale listing.
  It is a therapeutics developer, not a software vendor: it publishes no developer program, no public API, no SDKs and no
  machine-readable API description of any kind.'
url: https://raw.githubusercontent.com/api-evangelist/abgenomics/refs/heads/main/apis.yml
image: https://www.altrubio.com/assets/img/logo.png
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: 'enrichment pass 2026-09-06: full STEP 0b contract discovery run across abgenomics.com and the successor altrubio.com
  — no OpenAPI, GraphQL, MCP, A2A card, WSDL, proto or well-known document found; clinical-stage biopharma with no developer
  program'
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Therapeutics
- Clinical Research
- Immunology
- Oncology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/abgenomics-domain-security.yml
- type: Website
  url: https://www.altrubio.com/altrubio/en
- type: PrivacyPolicy
  url: https://www.altrubio.com/altrubio/en/privacy
- type: Support
  url: https://www.altrubio.com/altrubio/en/contact
x-successor:
  name: AltruBio, Inc.
  website: https://www.altrubio.com/altrubio/en
  note: AbGenomics rebranded as AltruBio, Inc. in 2020 (name change, new leadership, shift from oncology to immunology). The
    Website/PrivacyPolicy/Support pointers resolve to the successor's live site because the company's own abgenomics.com domain
    now serves an abovedomains.com "this domain may be for sale" parking page (HTTP 200, 1,005 bytes, ns1/ns2.abovedomains.com).
x-enrichment:
  date: '2026-09-06'
  status: minimal
  artifacts_added: 2
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: AbGenomics is a clinical-stage biopharmaceutical developer of antibody therapeutics (now trading as AltruBio) whose
    product is a drug pipeline, not software — its own abgenomics.com domain has been released to an abovedomains.com "this
    domain may be for sale" parking page, and the successor site altrubio.com publishes only pipeline, news and careers pages
    with no developer program, no API, no SDK and no /llms.txt.
  evidence:
  - url: https://abgenomics.com/
    status: 200
  - url: https://abgenomics.com/.well-known/apis.json
    status: 404
  - url: https://www.altrubio.com/altrubio/en
    status: 200
  - url: https://www.altrubio.com/llms.txt
    status: 200
  - url: https://api.github.com/orgs/abgenomics
    status: 404
  checked: '2026-09-06'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools →

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/abgenomics"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/abgenomics/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/abgenomics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.